In all the posts about why the PPS has not reflec
Post# of 36537
(Total Views: 448)
Posted On: 10/25/2020 11:09:36 AM
In all the posts about why the PPS has not reflected the good news about the vaccine deals (aside from the obvious market manipulation), something has yet to be brought up. At the GNBT website https://www.generex.com/, it is stated that “Generex Biotechnology is an integrated healthcare holding company...”. This fact will have direct implications on how investors will evaluate GNBT (see article) http://www.corporatevaluations.in/research-ar...-Companies. While we know GNBT has great potential, the article talks about value discounts based on actual performance. When the other pharmaceuticals released good news, their PPS reflected how the public felt because the public could buy their stock. With the NGIO news, the public can’t show how they feel because they can’t buy NGIO stock. Yes, the public can buy GNBT stock, but Generex is the “holding” company and its value is how much money it makes from the companies they hold, which currently is $0. This also holds true with any news about NuGenerex Therapeutics, NuGenerex Distribution Solutions and NuGenerex Diagnostics. Until the GNBT 8k and 10k/Qs start showing a profit for GNBT from the companies they hold, the public has really nothing to assign as a true GNBT PPS valuation other than what might/could be.
That being said, positive NGIO news is important as it lays the groundwork and gives the public exposure to NGIO, so when the IPO does come, NGIO is not an unknown company. Obviously the Peptide results are in and positive. Malaysia wouldn’t make an agreement and spend money otherwise. The key is to buildup the NGIO value pre-IPO so when the price point is fixed, the public will see it as justifiable. Why was Facebook IPO set at $38.00? Because the public knew Facebook and wanted a piece of the action. Joe is trying to do that with NGIO, so when the IPO is in effect and a price is established, the public will be pounding on the door like a (in the past) Walmart Black Friday special. NGIO news is for the benefit of NGIO not GNBT or its PPS.
We know the GNBT potential and so do the manipulators. That is why they can still adeptly play their shell games. But the general public is still ignorant of that fact. However once NGIO goes public and word is then spread about GNBT holding liquidity of NGIO PPS x 300+ million shares, they will see owning GNBT is like having money in the bank and buying gold bullion for 1/10 the going price. So perhaps less fretting about the GNBT PPS and more insight on how the NGIO public perception is being built up, might keep this board on a positive note. In the meantime, we can continue to add (if not already full) our GNBT stock at this ridiculous low GNBT share price.
That being said, positive NGIO news is important as it lays the groundwork and gives the public exposure to NGIO, so when the IPO does come, NGIO is not an unknown company. Obviously the Peptide results are in and positive. Malaysia wouldn’t make an agreement and spend money otherwise. The key is to buildup the NGIO value pre-IPO so when the price point is fixed, the public will see it as justifiable. Why was Facebook IPO set at $38.00? Because the public knew Facebook and wanted a piece of the action. Joe is trying to do that with NGIO, so when the IPO is in effect and a price is established, the public will be pounding on the door like a (in the past) Walmart Black Friday special. NGIO news is for the benefit of NGIO not GNBT or its PPS.
We know the GNBT potential and so do the manipulators. That is why they can still adeptly play their shell games. But the general public is still ignorant of that fact. However once NGIO goes public and word is then spread about GNBT holding liquidity of NGIO PPS x 300+ million shares, they will see owning GNBT is like having money in the bank and buying gold bullion for 1/10 the going price. So perhaps less fretting about the GNBT PPS and more insight on how the NGIO public perception is being built up, might keep this board on a positive note. In the meantime, we can continue to add (if not already full) our GNBT stock at this ridiculous low GNBT share price.
(6)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼